These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10770425)

  • 1. Graft-versus-host disease after liver transplantation: documentation by fluorescent in situ hybridisation and human leucocyte antigen typing.
    Au WY; Ma SK; Kwong YL; Ng IO; Hawkins BR; Wan TS; Liu CL; Fan ST; Lo CM
    Clin Transplant; 2000 Apr; 14(2):174-7. PubMed ID: 10770425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FISH diagnosis of acute graft-versus-host disease following living-related liver transplant.
    Kanehira K; Riegert-Johnson DL; Chen D; Gibson LE; Grinnell SD; Velgaleti GV
    J Mol Diagn; 2009 Jul; 11(4):355-8. PubMed ID: 19460938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal Graft-Versus-Host Disease Following Adult-To-Adult Living Donor Liver Transplantation From an HLA Nonhomozygous Donor.
    Yu YD; Kim DS; Ha N; Jung SW; Han JH; Kim JY; Park SH; Cho YJ
    Prog Transplant; 2016 Dec; 26(4):394-396. PubMed ID: 27555077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation.
    Taylor AL; Gibbs P; Sudhindran S; Key T; Goodman RS; Morgan CH; Watson CJ; Delriviere L; Alexander GJ; Jamieson NV; Bradley JA; Taylor CJ
    Transplantation; 2004 Feb; 77(3):441-6. PubMed ID: 14966423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of fluorescence in situ hybridization (FISH) analysis in diagnosing graft versus host disease following orthotopic liver transplant.
    Post GR; Black JS; Cortes GY; Pollack RB; Wolff DJ; Lazarchick J
    Ann Clin Lab Sci; 2011; 41(2):188-92. PubMed ID: 21844579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid molecular diagnosis of posttransfusion graft-versus-host disease by polymerase chain reaction.
    Hayakawa S; Chishima F; Sakata H; Fujii K; Ohtani K; Kurashina K; Hayakawa J; Suzuki K; Nakabayashi H; Esumi M
    Transfusion; 1993 May; 33(5):413-7. PubMed ID: 8488546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting graft-versus-host disease in HLA-identical bone marrow transplant: a comparison of T-cell frequency analysis and a human skin explant model.
    Dickinson AM; Sviland L; Wang XN; Jackson G; Taylor PR; Dunn A; Proctor SJ
    Transplantation; 1998 Oct; 66(7):857-63. PubMed ID: 9798694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way HLA matching.
    Kamei H; Oike F; Fujimoto Y; Yamamoto H; Tanaka K; Kiuchi T
    Liver Transpl; 2006 Jan; 12(1):140-5. PubMed ID: 16382466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnosis between graft-versus-host disease and hemophagocytic syndrome after living-related liver transplantation by mixed lymphocyte reaction assay.
    Hara H; Ohdan H; Tashiro H; Itamoto T; Tanaka Y; Mizunuma K; Tokita D; Onoe T; Ito R; Asahara T
    J Invest Surg; 2004; 17(4):197-202. PubMed ID: 15371161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute graft-versus-host disease after liver transplantation diagnosed by fluorescent in situ hybridization testing of skin biopsy specimens.
    Meves A; el-Azhary RA; Talwalkar JA; Moore SB; Brewer JD; Motsonelidze C; McNallan KT; Reed AM; Rosen CB
    J Am Acad Dermatol; 2006 Oct; 55(4):642-6. PubMed ID: 17010745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation.
    Goulmy E; Schipper R; Pool J; Blokland E; Falkenburg JH; Vossen J; Gratwohl A; Vogelsang GB; van Houwelingen HC; van Rood JJ
    N Engl J Med; 1996 Feb; 334(5):281-5. PubMed ID: 8532022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft-versus-host disease presenting with pancytopenia after en bloc multiorgan transplantation: case report and literature review.
    Mawad R; Hsieh A; Damon L
    Transplant Proc; 2009 Dec; 41(10):4431-3. PubMed ID: 20005417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lethal acute graft-versus-host disease in a liver transplant recipient: relations with cell migration and chimerism.
    Pageaux GP; Perrigault PF; Fabre JM; Portales P; Souche B; Dereure O; Eliaou JF; Larrey D; Domergue J; Michel H
    Clin Transplant; 1995 Feb; 9(1):65-9. PubMed ID: 7742585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Graft-vs.-host reaction: a severe complication after orthotopic liver transplantation].
    Neumann U; Knoop M; Langrehr JM; Kaisers U; Bechstein WO; Blumhardt G; Lobeck H; Riess H; Neuhaus P
    Zentralbl Chir; 1995; 120(6):478-81. PubMed ID: 7639037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings.
    Theobald M; Nierle T; Bunjes D; Arnold R; Heimpel H
    N Engl J Med; 1992 Dec; 327(23):1613-7. PubMed ID: 1435898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catastrophic graft-versus-host disease after lung transplantation proven by PCR-based chimerism analysis.
    Worel N; Bojic A; Binder M; Jaksch P; Mitterbauer G; Streubel B; Thalhammer F; Staudinger T; Laczika KF; Locker GJ
    Transpl Int; 2008 Nov; 21(11):1098-101. PubMed ID: 18764830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute graft-versus-host disease in pancreas transplantation: a comparison of two case presentations and a review of the literature.
    Weinstein A; Dexter D; KuKuruga DL; Philosophe B; Hess J; Klassen D
    Transplantation; 2006 Jul; 82(1):127-31. PubMed ID: 16861952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation.
    Wang XN; Taylor PR; Skinner R; Jackson GH; Proctor SJ; Hedley D; Dickinson AM
    Transplantation; 2000 Aug; 70(3):488-93. PubMed ID: 10949192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.